The primary goal is to predict the clinical outcomes of mother and baby using blood glucose and other routinely collected clinical data in pregnancy to predict adverse outcomes at birth in women with GDM. The secondary goal is to develop models to predict optimal blood glucose testing schedules for pregnant women. Exploratory Objectives are (1) to understand patterns of dosage and / or medication choice and (2) to describe different phenotypes of gestational diabetes based on multiple data input.
Age range
18 Years – 99 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Clinical outcome of mothers at birth
Timeframe: From enrollment to the delivery date, assesed upto 52 weeks.
Clinical outcome of mothers after birth
Timeframe: From the delivery date to the date that mother was discharged from the hospital, assessed up to 52 weeks, whichever come first.
Clinical outcome of neonates at birth
Timeframe: From enrollment to the delivery date to the date to giving birth, assesed upto 52 weeks.
Clinical outcome of neonates after birth
Timeframe: From the delivery date to the date that neonate was discharged from the hospital, assessed up to 52 weeks, whichever come first.